Colgate-Palmolive Company CL
95.62 USD -1.81 (-1.86%)
At closeNov 3, 2026, 7:17 PM EST
95.62 0.00 0.00%
After hours · Nov 3, 7:17 PM ET
95.25 Day range 96.90
75.00 52-week range 99.33
- YTD
- +21.01%
- 1 year
- +27.53%
Analyst view
Consensus: buy
Buy
Price target (mean) 101.70 +6.4% upside
Now 95.62
- Target (low)
- 88.00
- Target (mean)
- 101.70
- Target (high)
- 112.00
Ratings (0m) 21 13 buy · 7 hold · 1 sell
- Strong buy6
- Buy7
- Hold7
- Sell0
- Strong sell1
Recommendation trend
- This month 21
- 1 month ago 21
- 2 months ago 21
- 3 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.97964 | 0.958 – 1.02 | 0.95 | +3.1% | 5.36B | +2.5% | 17 |
| Next quarter | 0.97352 | 0.885 – 1.02 | 0.97 | +0.4% | 5.44B | +2.1% | 13 |
| Current year | 3.92 | 3.88 – 4.02 | 3.69 | +6.4% | 21.40B | +5.0% | 19 |
| Next year | 4.10 | 3.97 – 4.25 | 3.92 | +4.5% | 21.89B | +2.3% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 2, 2026 | UBS | Maintained | Buy | Buy |
| Nov 2, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 2, 2026 | BNP Paribas | Reiterated | Outperform | Outperform |
| Nov 2, 2026 | TD Cowen | Maintained | Hold | Hold |
| Nov 2, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 2, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 2, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Nov 2, 2026 | B of A Securities | Maintained | Buy | Buy |
| Oct 19, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 5, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Sep 21, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Sep 8, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 3, 2026 | UBS | Maintained | Buy | Buy |
| Aug 3, 2026 | TD Cowen | Maintained | Hold | Hold |
| Aug 3, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 3, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 3, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 21, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 16, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 16, 2026 | UBS | Maintained | Buy | Buy |
| Jul 14, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 9, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 8, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jun 11, 2026 | Bernstein | Initiated | — | Market Perform |
| May 5, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 4, 2026 | UBS | Maintained | Buy | Buy |
| May 4, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Apr 23, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
